MGMT and astrocytoma (excluding glioblastoma): Variables associated with statistically significant differences in survival in patients with IDH-wt astrocytoma found in univariate analyses (age > 65 years, ECOG, EOR) as well as several putatively clinically significant variables (adjuvant treatment, MGMT methylation status) were included in a multivariate survival analysis.